Health Condition 1: I10- Essential (primary) hypertension
Conditions
Interventions
Intervention1: Amyl nitrosum Mother Tincture,
Placebo: 1)Amyl nitrosum Mother Tincture
Dose 10drops in water Twice daily for 5 days followed by
2)Placebo 5 pills Twice daily for 10 days
Duration of t
Sponsors
Dr Jyoti A Moolabharati
Eligibility
Inclusion criteria
Inclusion criteria: 1) Subjects on antihypertensive drugs. 2) Subjects who fulfill the diagnostic criteria. History, examination and routine investigation show no evidence of secondary causes. 3) Essential hypertension Grade 1 and Grade 2. 4) Subjects who are willing to take part in the study and sign the written in format consent.
Exclusion criteria
Exclusion criteria: 1) Subjects with history or routine investigations, which suggest any evidence of a secondary cause for the hypertension. 2) High risk group (Grade 3). 3) Subjects with isolated systolic hypertension. 4) Presence of any systemic illnesses (endocrinal / cardiovascular/ locomotor/ neurological/ pyschiatry etc) that was already diagnosedor detected clinically or in routine lab investigation. 5) Pregnant and lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assessing the effectiveness of Amyl nitrosum mother tincture versus placebo with anti hypertensive drugs in the treatment of Essential HypertensionTimepoint: Initial follow up for once a week for one month. Study will be continued for 6 months. | — |
Secondary
| Measure | Time frame |
|---|---|
| At the end of the study, to know about Essential Hypertension with respect to: Definition Epidemiology Etiology Pathogenesis Clinical Features Diagnosis Timepoint: Each case is followed up for 6months. | — |
Countries
India
Contacts
Public ContactDr Jyoti A Moolabharati
Jawaharlal Nehru Homoeopathic Medical College , Parul University, Gujarat
Outcome results
None listed